Scroll Top

Wegovy cuts heart risks by 20% in large trial

Wegovy cuts heart risks by 20% in large trial

In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%…
Read More

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.